These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 31407169)

  • 1. Detection of bacteria in blood circulation in patients receiving cancer chemotherapy.
    Ota A; Morita S; Matsuoka A; Shimokata T; Maeda O; Mitsuma A; Yagi T; Asahara T; Ando Y
    Int J Clin Oncol; 2020 Jan; 25(1):210-215. PubMed ID: 31407169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis.
    Moghnieh R; Estaitieh N; Mugharbil A; Jisr T; Abdallah DI; Ziade F; Sinno L; Ibrahim A
    Front Cell Infect Microbiol; 2015; 5():11. PubMed ID: 25729741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer chemotherapy treatment patterns and febrile neutropenia in the US Veterans Health Administration.
    Wang L; Barron R; Baser O; Langeberg WJ; Dale DC
    Value Health; 2014 Sep; 17(6):739-43. PubMed ID: 25236998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for febrile neutropenia among patients with cancer receiving chemotherapy: A systematic review.
    Lyman GH; Abella E; Pettengell R
    Crit Rev Oncol Hematol; 2014 Jun; 90(3):190-9. PubMed ID: 24434034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of bacteria and fungi in blood of patients with febrile neutropenia by real-time PCR with universal primers and probes.
    Teranishi H; Ohzono N; Inamura N; Kato A; Wakabayashi T; Akaike H; Terada K; Ouchi K
    J Infect Chemother; 2015 Mar; 21(3):189-93. PubMed ID: 25497674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risks and consequences of travel burden on prophylactic granulocyte colony-stimulating factor administration and incidence of febrile neutropenia in an aged Medicare population.
    Stephens JM; Bensink M; Bowers C; Hollenbeak CS
    Curr Med Res Opin; 2019 Feb; 35(2):229-240. PubMed ID: 29661043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. c-D-index is a risk factor for prolonged febrile neutropenia during chemotherapy in patients with acute myeloid leukemia.
    Kubo H; Imataki O; Kubo YH; Uemura M; Kadowaki N
    Int J Clin Oncol; 2019 May; 24(5):590-595. PubMed ID: 30604157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of the Risk Factors of Febrile Neutropenia Among 72 Women Receiving FEC in Early Breast Cancer Chemotherapy].
    Ishii N; Fujimori T; Kasagawa T; Udagawa I
    Gan To Kagaku Ryoho; 2016 Nov; 43(12):1555-1557. PubMed ID: 28133055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of repeat blood cultures during febrile neutropenia in adult acute myeloid leukaemia patients undergoing intensive chemotherapy.
    Kimura SI; Gomyo A; Hayakawa J; Tamaki M; Akahoshi Y; Harada N; Ugai T; Kusuda M; Kameda K; Wada H; Ishihara Y; Kawamura K; Sakamoto K; Sato M; Terasako-Saito K; Kikuchi M; Nakasone H; Kako S; Tanihara A; Kanda Y
    Infect Dis (Lond); 2017 Oct; 49(10):748-757. PubMed ID: 28631944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical efficacy of cycling empirical antibiotic therapy for febrile neutropenia in pediatric cancer patients.
    Teranishi H; Koga Y; Nishio H; Kato W; Ono H; Kanno S; Nakashima K; Takada H
    J Infect Chemother; 2017 Jul; 23(7):463-467. PubMed ID: 28527651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacteremia in febrile cancer patients in Uganda.
    Lubwama M; Phipps W; Najjuka CF; Kajumbula H; Ddungu H; Kambugu JB; Bwanga F
    BMC Res Notes; 2019 Jul; 12(1):464. PubMed ID: 31362783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of age group on febrile neutropenia risk assessment and management in patients with diffuse large B-cell lymphoma treated with R-CHOP regimens.
    Lugtenburg P; Silvestre AS; Rossi FG; Noens L; Krall W; Bendall K; Szabo Z; Jaeger U
    Clin Lymphoma Myeloma Leuk; 2012 Oct; 12(5):297-305. PubMed ID: 23040435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The incidence and risk factors of febrile neutropenia in chemotherapy-naïve lung cancer patients receiving etoposide plus platinum.
    Fujiwara T; Kenmotsu H; Naito T; Kawamura T; Mamesaya N; Kotake M; Kobayashi H; Omori S; Nakashima K; Wakuda K; Ono A; Taira T; Murakami H; Omae K; Mori K; Endo M; Takahashi T
    Cancer Chemother Pharmacol; 2017 Jun; 79(6):1229-1237. PubMed ID: 28455585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of febrile neutropenia in solid organ malignancies following chemotherapy.
    Lakshmaiah KC; Abhayakumar SM; Shetty R; Loknath D; Jayashree RS; Govindbabu K
    J Cancer Res Ther; 2014; 10(3):540-3. PubMed ID: 25313735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours.
    Aapro MS; Bohlius J; Cameron DA; Dal Lago L; Donnelly JP; Kearney N; Lyman GH; Pettengell R; Tjan-Heijnen VC; Walewski J; Weber DC; Zielinski C;
    Eur J Cancer; 2011 Jan; 47(1):8-32. PubMed ID: 21095116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Febrile Neutropenia Rates According to Body Mass Index and Dose Capping in Women Receiving Chemotherapy for Early Breast Cancer.
    Lote H; Sharp A; Redana S; Papadimitraki E; Capelan M; Ring A
    Clin Oncol (R Coll Radiol); 2016 Sep; 28(9):597-603. PubMed ID: 26936608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of granulocyte colony stimulating factor (G-CSF) and management of chemotherapy delivery during adjuvant treatment for early-stage breast cancer--further observations from the IMPACT solid study.
    Mäenpää J; Varthalitis I; Erdkamp F; Trojan A; Krzemieniecki K; Lindman H; Bendall K; Vogl FD; Verma S
    Breast; 2016 Feb; 25():27-33. PubMed ID: 26801413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Modalities of management of cancer patients with febrile neutropenia in the oncology emergency unit of Gustave-Roussy and their related costs].
    Borget I; Antoun S; Chachaty E; Gachot B; Alibay A; Di Palma M; Merad M
    Bull Cancer; 2014 Oct; 101(10):925-31. PubMed ID: 25373692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic susceptibility of Gram-negatives isolated from bacteremia in children with cancer. Implications for empirical therapy of febrile neutropenia.
    Castagnola E; Caviglia I; Pescetto L; Bagnasco F; Haupt R; Bandettini R
    Future Microbiol; 2015; 10(3):357-64. PubMed ID: 25812459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical implications of icaA and icaD genes in coagulase negative staphylococci and Staphylococcus aureus bacteremia in febrile neutropenic pediatric cancer patients.
    El-Mahallawy HA; Loutfy SA; El-Wakil M; El-Al AK; Morcos H
    Pediatr Blood Cancer; 2009 Jul; 52(7):824-8. PubMed ID: 19214976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.